全文获取类型
收费全文 | 4280118篇 |
免费 | 350987篇 |
国内免费 | 15295篇 |
专业分类
耳鼻咽喉 | 60916篇 |
儿科学 | 133053篇 |
妇产科学 | 111908篇 |
基础医学 | 655084篇 |
口腔科学 | 118743篇 |
临床医学 | 388003篇 |
内科学 | 775425篇 |
皮肤病学 | 103283篇 |
神经病学 | 366538篇 |
特种医学 | 170576篇 |
外国民族医学 | 912篇 |
外科学 | 651945篇 |
综合类 | 126127篇 |
现状与发展 | 23篇 |
一般理论 | 2582篇 |
预防医学 | 362530篇 |
眼科学 | 100466篇 |
药学 | 301951篇 |
24篇 | |
中国医学 | 11355篇 |
肿瘤学 | 204956篇 |
出版年
2021年 | 55693篇 |
2020年 | 35479篇 |
2019年 | 58611篇 |
2018年 | 73236篇 |
2017年 | 55912篇 |
2016年 | 62223篇 |
2015年 | 75495篇 |
2014年 | 110235篇 |
2013年 | 175561篇 |
2012年 | 117743篇 |
2011年 | 120731篇 |
2010年 | 122897篇 |
2009年 | 126023篇 |
2008年 | 107861篇 |
2007年 | 114371篇 |
2006年 | 123853篇 |
2005年 | 118980篇 |
2004年 | 119955篇 |
2003年 | 110599篇 |
2002年 | 101193篇 |
2001年 | 154290篇 |
2000年 | 150446篇 |
1999年 | 139524篇 |
1998年 | 71256篇 |
1997年 | 67740篇 |
1996年 | 65620篇 |
1995年 | 61485篇 |
1994年 | 55564篇 |
1993年 | 51597篇 |
1992年 | 103557篇 |
1991年 | 98946篇 |
1990年 | 94048篇 |
1989年 | 91678篇 |
1988年 | 85303篇 |
1987年 | 83769篇 |
1986年 | 79461篇 |
1985年 | 77903篇 |
1984年 | 65933篇 |
1983年 | 58849篇 |
1982年 | 48128篇 |
1981年 | 44869篇 |
1980年 | 42162篇 |
1979年 | 57832篇 |
1978年 | 47030篇 |
1977年 | 41590篇 |
1976年 | 38651篇 |
1975年 | 37845篇 |
1974年 | 42414篇 |
1973年 | 40547篇 |
1972年 | 38017篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
A. FERREIRA MENDES M. M. CARAMONA M. CELESTE LOPES 《The Journal of pharmacy and pharmacology》1996,48(3):302-305
The aim of this work was to compare the subcellular distribution of the oestrogen receptor from the uteri of rats treated with vehicle alone (control group), oestradiol or one of the antio-estrogenic drugs tamoxifen and ZD 182,780. The nuclear, microsomal and cytosolic oestrogen receptor contents were evaluated by an immunoenzymatic method (“ER-EIA” kit from Abbott Laboratories) and the results in each fraction were expressed as a percentage of the total number of receptors. Parallel studies were performed to assess the uterotrophic effect of these drugs and to assess that they had reached the uterus. In the control group, we found that the oestrogen receptor was distributed mainly between the microsomal (29.1 ± 1.3%) and cytosolic (68.1 ±0.9%) fractions, with only a small amount located in the nucleus (2.8 ± 0.5%). When oestradiol was administered, the oestrogen receptor distribution was: nuclear 11.7 ± 2.0, microsomal 15.5 ± 1.3 and cytosolic 72.8 ± 3.3% and, in the tamoxifen group, the results were: nuclear 18.5 ± 1.5, microsomal 26.0 ± 31 and cytosolic 55.5 ± 3.4%, which shows a relative shift both to the control and the oestradiol-treated groups. In the uteri of rats treated with ZD 182,780 the results were very similar to those obtained in the control group. Our results indicate that the subcellular distribution of the oestrogen receptor varies according to the drug administered and that this receptor may not be located in a single subcellular compartment. Moreover, the nuclear uptake of the ZD 182,780-oestrogen receptor complex seems to be blocked, possibly due to impaired receptor dimerization. In the case of tamoxifen, the intracellular transport of the receptor also seems to be blocked, probably due to the nuclear retention of the receptor, thus suggesting that tamoxifen must impair the oestrogen receptor function on a step subsequent to the receptor dimerization. 相似文献
992.
Summary Contradictory immunohistochemical data have been reported on the localization of N-acetylaspartylglutamate in the rat forebrain, using different carbodiimide fixation protocols and antibody purification methods. In one case, N-acetylaspartylglutamate immunoreactivity was observed in apparent interneurons throughout all allocortical and isocortical regions, suggesting possible colocalization with GABA. In another case, strong immunoreactivity was observed in numerous pyramidal cells in neocortex and hippocampus, suggesting colocalization with glutamate or aspartate. Reconciling these disparate findings is crucial to understanding the role of N-acetylaspartylglutamate in nervous system function. Antibodies to N-acetylaspartylglutamate and a structurally related molecule, N-acetylaspartate, were purified in stages, and their cross-reactivities with protein conjugates of N-acetylaspartylglutamate and N-acetylaspartate were monitored at each stage by solidphase immunoassay. Reduction of the cross-reactivity of the anti-N-acetylaspartylglutamate antibodies to N-acetylaspartateprotein conjugates to about 1% eliminated significant staining of most pyramidal neurons in the rat forebrain. Utilizing highly purified antibodies, the distributions of N-acetylaspartylglutamate and N-acetylaspartate were examined in several major telencephalic and diencephalic regions of the rat, and were found to be distinct. N-acetylaspartylglutamate-immunoreactivity was observed in specific neuronal populations, including many groups thought to use GABA as a neurotransmitter. Among these were the globus pallidus, ventral pallidum, entopeducular nucleus, thalamic reticular nucleus, and scattered non-pyramidal neurons in all layers of isocortex and allocortex. N-acetylaspartate-immunoreactivity was more broadly distributed than N-acetylaspartylglutamate-immunoreactivity in the rat forebrain, appearing strongest in many pyramidal neurons. Although N-acetylaspartate-immunoreactivity was found in most neurons, it exhibited a great range of intensities between different neuronal types. 相似文献
993.
994.
995.
J. de Pedro-Cuesta V. Abraira G.-X. Jiang G. Solders S. Fredrikson 《Acta neurologica Scandinavica》1996,93(2-3):175-183
Using hierarchical cluster analysis, applied to 47 cases of Guillain-Barre Syndrome (GBS) incident in South-West Stockholm (SWS) during the period from January 1973 to June 1992, we identified three major clinicoepidemiological subgroups. The first subgroup, 25.5% of the cases (26.7 ± 6.7 years), recorded a peak incidence at ages 20–29 years and presented significant differences from other subgroups, a high proportion of cases with onset at low age preceded by respiratory infection (83.3%) and with normal motor conduction velocity (50.0%). Also found, were less affected biological parameters, a rapidly progressive course and independence in gait at one month after onset. A second subgroup, 27.7% of cases, was severely affected, clinically and functionally. It consisted predominantly of young individuals (22.7 ± 11.1 years), with a high incidence (69.2% of cases) in autumn. A third subgroup, comprising 40.47; of cases, was older (61.1 ± 11.0 years) and, in general, also severely affected. The incidence of this form appeared to be invariant with time. 相似文献
996.
997.
W. Hughes A. Barr B. C. Dow† E. A. C. Follett † J. A. J. Barbara‡ 《Transfusion medicine (Oxford, England)》1995,5(3):225-230
SUMMARY. Samples from 1828 donations were screened for anti-HBc at seven sites in the UK using kits supplied by 10 manufacturers. Only 10 (0.55%) donations were considered to have true anti-HBc reactivity and these were detected by all 10 kits. Additional markers of HBV infection were found in nine of these 10 donations. Additional reactives were found by all kits, the number ranging from 1 to 43.
In the four more specific kits, the 10 true reactives were clearly distinguished from the 'false reactives' by the strength of the reaction. It is concluded that the reliance on a single ELISA test for anti-HBc diagnosis is unwise. The use of a second test known to be more specific than the screening ELISA is recommended. 相似文献
In the four more specific kits, the 10 true reactives were clearly distinguished from the 'false reactives' by the strength of the reaction. It is concluded that the reliance on a single ELISA test for anti-HBc diagnosis is unwise. The use of a second test known to be more specific than the screening ELISA is recommended. 相似文献
998.
In the present study, we examined the effect of CsA on the in vitro production of Ig and on the in vitro production of molecules known to have B-cell growth and differentiation activities, such as IL-6 and sCD23. For the purpose of this study, we developed an experimental In vitro system closely resembling an In vivo model of ongoing B-cell activation. Pre-activated B cells proliferated and produced IgM optimally when they were re-cultured in the presence of IL-2/IL-6. CsA down-regulated the IL-2/IL-6-induced proliferative responses of pre activated B cells by at least 50%., but it up-regulated IgM production in the same experiments. This up regulating effect was not cytokine-related since it was also seen when cells were re-cultured in the absence of any cytokines. Optimal release of sCD23 was observed when SAC-pre-activated B cells were re cultured in the presence of IL-4 or IL-4 plus IL-2 and CsA up-regulated significantly the release of this molecule in these cultures. Finally, CsA was shown to inhibit PHA-induced cell proliferation of PBMC and to up-rcgulate IL-6 production in the same cultures. We conclude that CsA can amplify in vitro both the production of Ig and the release of sCD23 by pre activated B cells. This finding, in combination with the CsA-induced up-regulation of lectin-induced IL-6 production, may have clinical implications in disease states with an ongoing immune activation, where prolonged administration of CsA might be anticipated. 相似文献
999.
1000.